If you have been reading about Investigational drug and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-01-31. Numbers and descriptions here follow the published literature rather than marketing material.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
| Property | Value | Notes |
|---|---|---|
| Common name | Cardarine | Common internet and media name. |
| Research code | GW501516 | Also written GW-1516. |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator. |
| Development status | Discontinued | Clinical development halted after rodent cancer findings. |
| Regulatory status | Prohibited in sport | Listed by WADA; not approved as medicine. |
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
== References == McGraw-Hill Encyclopedia of Science & Technology (10th ed.). New York: McGraw-Hill. 2007. ISBN 978-0-07-144143-8. Serway, Raymond A.; Moses, Clement J.; Moyer, Curt A. (1989), Modern Physics, Fort Worth: Harcourt Brace Jovanovich, ISBN 0-03-004844-3 Simmons, George F. (1972), Differential Equations with Applications and Historical Notes, New York: McGraw-Hill, LCCN 75173716
Other existing alpine glacial isotope records include Mount Kilimanjaro in Tanzania, Mount Altai and West Belukha Plateau in Russia, Mount Logan in Canada, the Fremont Glacier in Wyoming, USA, and the Illimani Ice Core in Bolivia, most of which cover an interval of the Holocene epoch.[3]
Catching a chameleon: mRNA can be engineered to overcome cancer evolution, essay by Elias Sayour, a pediatric oncologist. Science (journal), 2 Apr 2026 "Five things you need to know about: mRNA vaccines". Horizon. Archived from the original on 4 April 2020. Retrieved 17 November 2020. "RNA vaccines: an introduction". PHG Foundation. University of Cambridge. "Understanding mRNA COVID-19 Vaccines". Centers for Disease Control and Prevention. 4 January 2022. Kolata G, Mueller B (15 January 2022). "Halting Progress and Happy Accidents: How mRNA Vaccines Were Made". The New York Times. M.I.T. Lecture 10: Kizzmekia Corbett, Vaccines" on YouTube
Global hypomethylation results in decreased genomic stability, while local hypermethylation of tumour suppressor gene promoters often accounts for their loss of function. Specific patterns of methylation are indicative of specific cancer types, have prognostic value, and can help to guide the best course of treatment. Large-scale epigenome mapping efforts are under way around the world and have been organized under the Human Epigenome Project. This is based on a multi-tiered strategy, whereby bisulfite sequencing is used to obtain high-resolution methylation profiles for a limited number of reference epigenomes, while less thorough analysis is performed on a wider spectrum of samples. This approach is intended to maximize the insight gained from a given amount of resources, as high-resolution genome-wide mapping remains a costly undertaking. Gene-set analysis (for example using tools like DAVID and GoSeq) has been shown to be severely biased when applied to high-throughput methylation data (e.g. genome-wide bisulfite sequencing); it has been suggested that this can be corrected using sample label permutations or using a statistical model to control for differences in the numberes of CpG probes / CpG sites that target each gene.
Sources: en.wikipedia.org
Michael F. Holick ( HOLL-ik; born 1946) is an internationally prominent physician-scientist, and endocrinologist. He is a professor of medicine at the Boston University Medical Center and editor-in-chief of the journal Clinical Laboratory. As a result of controversies associated with his medical practice, he has been forbidden from treating patients at the Boston Medical Center since 2017.
== Delivery == In 2015, Jain et al. described a trans-acting DNA-based amphiphatic delivery system for convenient delivery of poly A tailed uncharged nucleic acids (UNA) such as PNAs and morpholinos, so that several UNA's can be easily screened ex vivo.
The Portuguese Republican Party (Portuguese: Partido Republicano Português, pronounced [pɐɾˈtiðu ʁɛpuβliˈkɐnu puɾtuˈɣeʃ]) was a Portuguese political party formed during the late years of the constitutional monarchy that proposed and later brought about the replacement of the monarchy with the Portuguese First Republic. When the Republic was established on the 5 October 1910 Revolution, the members of the party initially stood together, but soon began splitting into different parties, including the Democratic Party, Republican Union, and Evolutionist Party, some of which themselves later merged or split to form the Democratic Leftwing Republican Party, Reformist Party, Centrist Republican Party, Popular Party, Radical Party, Republican Liberal Party, Liberal Republican Union, Reconstitution Party and Nationalist Republican Party.
== History == The term operando first appeared in catalytic literature in 2002. It was coined by Miguel A. Bañares, who sought to name the methodology in a way that captured the idea of observing a functional material – in this case a catalyst – under actual working, i.e. device operation, conditions. The first international congress on operando spectroscopy took place in Lunteren, Netherlands, in March 2003, followed by further conferences in 2006 (Toledo, Spain), 2009 (Rostock, Germany), 2012 (Brookhaven, USA), and 2015 (Deauville, France). The name change from in situ to operando for the research field of spectroscopy of catalysts under working conditions was proposed at the Lunteren congress. The analytical principle of measuring the structure, property and function of a material, a component disassembled or as part of a device simultaneously under operation conditions is not restricted to catalysis and catalysts. Batteries and fuel cells have been subject to operando studies with respect to their electrochemical function.
== Detectors == There are various cryogenic detectors which are used to detect particles. For cryogenic temperature measurement down to 30 K, Pt100 sensors, a resistance temperature detector (RTD), are used. For temperatures lower than 30 K, it is necessary to use a silicon diode for accuracy.
Sources: en.wikipedia.org
No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.
Preclinical rodent studies reported cancers, including liver and bladder tumors, at tested doses. The human relevance of those findings is uncertain, but development was discontinued. No approved human product resulted.
No. It remains an investigational compound without approved therapeutic labeling. Sports regulators prohibit its use, and health agencies have warned against consuming it.
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.